ABSTRACT Introduction: Multiple Sclerosis (MS) is a progressive disease leading to
increasing disability and costs. A literature review was carried out to identify MS costs and to …

Background Multiple sclerosis has both high healthcare and social impacts. Objective The
purpose of this article is to analyse the available literature describing the economic burden …

Objective To estimate, according to the states of disease (remission or relapse) and her level
of progression (EDSS), the cost of treatment of Multiple Sclerosis (MS) in Colombia. Methods …

This cost-of-illness analysis is based on information from 1.848 patients in Spain and is part
of a Europe-wide study on the costs of multiple sclerosis. The objective was to analyze the …

Multiple sclerosis (MS) is a disease of the CNS, typically striking adults during the primary
productive time of their life. The symptoms of MS can restrict the individual's physical activity …

A cross-sectional cost-of-care study was performed to assess the economic burden of
multiple sclerosis (MS) in France, Germany and the UK. Patients were stratified into 3 groups …

Objectives: To estimate average annual cost per multiple sclerosis (MS) patient in the US
using published estimates from the literature. Methods: A search was performed of English …

Multiple sclerosis (MS) is a disease of the central nervous system (CNS) that affects young
adults. Survival is long, more than 35 years, and consequently the disease has a huge …

In Poland, a data on MS costs is lacking. AIM. The systematic review of cost of illness studies
was conducted to estimate the average annual cost of MS patient and its breakdown …

Introduction This study assessed the societal costs of multiple sclerosis (MS) in Lebanon,
categorized by disease severity. Methods This was a cross-sectional, prevalence-based …